US · IVF
INVO Fertility, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Sarasota, FL 34240
- Website
- invobioscience.com
Price · as of 2024-12-31
$1.90
Market cap 224.52K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $1,569.55 | +82,507.89% |
| Intrinsic Value(DCF) | $74,896.57 | +3,941,824.74% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $0.00 | $0.00 | |||
| 2011 | $0.00 | $0.00 | |||
| 2012 | $0.00 | $748.45 | |||
| 2013 | $0.00 | $2,926.03 | |||
| 2014 | $0.00 | $4,641.91 | |||
| 2015 | $0.00 | $124.56 | |||
| 2016 | $0.00 | $0.00 | |||
| 2017 | $0.00 | $0.00 | |||
| 2018 | $0.00 | $0.00 | |||
| 2019 | $0.00 | $0.00 | |||
| 2020 | $30,124.80 | $17,599.10 | $291,280.06 | $0.00 | $156.35 |
| 2021 | $13,420.80 | $5,433.28 | $5,708,991.88 | $0.00 | $0.00 |
| 2022 | $3,398.40 | $1,374.84 | $329.01 | $0.00 | $308.12 |
| 2023 | $348.48 | $271.67 | $47,398.37 | $0.00 | $0.00 |
| 2024 | $89.28 | $1,569.55 | $1,587,555.81 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates INVO Fertility, Inc.'s (IVF) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $1,569.55
- Current price
- $1.90
- AI upside
- +82,507.89%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$74,896.57
+3,941,824.74% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| IVF | INVO Fertility, Inc. | $1.90 | 224.52K | +82,508% | +3,941,825% | — | — | -3.04 | 2.17 | 4.23 | -5.15 | -0.62 | -0.96 | 44.00% | -124.40% | -139.25% | -133.37% | -56.16% | -28.01% | 0.78 | -7.69 | 0.07 | 0.05 | -1.28 | 48841.00% | 11625.00% | -3926.00% | -11.43% | -0.17 | -21.88% | 0.00% | 0.00% | 0.00% | -4.53 | -11.65 | 5.63 | -2.40 |
About INVO Fertility, Inc.
INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.
- CEO
- Steven Shum
- Employees
- 30
- Beta
- 2.66
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($74,896.57 ÷ $1.90) − 1 = +3,941,824.74% (DCF, example).